Filter by content type
Filter by year
Vaccinex, Inc. to Participate in Podium and Poster Sessions at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
September 27, 2018 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based …
Vaccinex Announces $3 Million Award from the Alzheimer’s Drug Discovery Foundation
December 10, 2019 - … and our collaboration with Merck KGaA in Non-Small Cell Lung Cancer could bring important benefits to our patients … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … and our collaboration with Merck KGaA in Non-Small Cell Lung Cancer could bring important benefits to our patients …
Vaccinex, Inc. to Present Data on Its Semaphorin 4D Monoclonal Antibody Programs at Two Conferences Focused on Cancer Immunotherapy and Huntington’s Disease
November 6, 2018 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based …
Vaccinex Announces Pricing of Initial Public Offering
August 9, 2018 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based in …
Top-Line Results of Phase 2 SIGNAL Study in Huntington’s Disease Support Potential for Cognitive Benefit of Pepinemab
September 22, 2020 - … with avelumab checkpoint inhibitor in Non-Small Cell Lung Cancer . A new collaboration with Merck to test the … with currently active clinical trials in Non-Small Cell Lung Cancer , Huntington’s and Alzheimer’s disease and a … with avelumab checkpoint inhibitor in Non-Small Cell Lung Cancer . A new collaboration with Merck to test the …
Preclinical Data on Vaccinex, Inc. Anti-SEMA4D Monoclonal Antibody in Combination with Checkpoint Inhibitors Published in Cancer Immunology Research
December 12, 2018 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based …
Vaccinex, Inc. Presented Previously Disclosed Data from Ongoing Phase 1/2 Trial of VX15/2503 (Pepinemab) in Huntington’s Disease (the “SIGNAL Trial”) at Cambridge Healthtech Institute’s 18th Annual PepTalk
January 17, 2019 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. Vaccinex is based …
Vaccinex Reports Groundbreaking Findings at Medical Conferences Supporting Development of Pepinemab for the Treatment of Neurodegenerative Diseases and Cancer
September 26, 2023 - … double ORR in patients with PD-L1-low non-small cell lung cancer (NCT03268057) [3]. In view of these clinical … in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer . Clin Cancer Res . 2021 Jul 1 ;27(13):3630-3640. … KEYTRUDA in combination with chemotherapy in R/M HNSCC, lung cancer, metastatic PDAC and other indications, the …
Vaccinex, Inc. to Present at the Virtual Investor Fireside Chat Series
June 9, 2020 - … clinical trials in Huntington’s disease and Non-Small Cell Lung Cancer . Vaccinex is based in Rochester, New York . … clinical trials in Huntington’s disease and Non-Small Cell Lung Cancer . Vaccinex is based in Rochester, New York . … clinical trials in Huntington’s disease and Non-Small Cell Lung Cancer . Vaccinex is based in Rochester, New York . …
Vaccinex, Inc. to Present at the Virtual Investor KOL Roundtable
October 26, 2020 - … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. The company is also … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. The company is also … with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington’s disease. The company is also …
Pagination
- Previous page
- Page 5
- Next page